Concepedia

Charlotte Smetcoren

CS

Statistics

Publications

4

Citations

941

H-Index

4

Active since

2011

Affiliations

Alexion Pharmaceuticals (United States)(Current)

International University of Health and Welfare

Fondazione IRCCS Istituto Neurologico Carlo Besta

Stanford University

National Hospital Organization Hanamaki Hospital

Charlotte Smetcoren is an author at Alexion Pharmaceuticals (United States) specializing in medicine and pharmacology.

Top concepts

Publications per year

2011–2020

4

Publications

4

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study

Maarten Schrooten, Charlotte Smetcoren, Wim Robberecht et al. · Annals of Neurology · 2011 · 99 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

1–4 of 4